GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » 3-Year ROIIC %

Instadose Pharma (Instadose Pharma) 3-Year ROIIC % : 0.00% (As of Nov. 2021)


View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Instadose Pharma does not have enough data to calculate 3-Year ROIIC %.


Instadose Pharma 3-Year ROIIC % Historical Data

The historical data trend for Instadose Pharma's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma 3-Year ROIIC % Chart

Instadose Pharma Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21
3-Year ROIIC %
Get a 7-Day Free Trial - - - - -

Instadose Pharma Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Instadose Pharma's 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Instadose Pharma's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Instadose Pharma's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instadose Pharma's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Instadose Pharma's 3-Year ROIIC % falls into.



Instadose Pharma 3-Year ROIIC % Calculation

Instadose Pharma's 3-Year ROIIC % for the quarter that ended in Nov. 2021 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -0.469 (Nov. 2021) - -0.023 (Nov. 2018) )/( 0 (Nov. 2021) - 0 (Nov. 2018) )
=-0.446/
=N/A%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Instadose Pharma  (OTCPK:INSD) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Instadose Pharma 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Instadose Pharma (Instadose Pharma) Business Description

Traded in Other Exchanges
N/A
Address
5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6
Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.

Instadose Pharma (Instadose Pharma) Headlines

From GuruFocus